Pure Bioscience, Inc. (PURE) - Financial and Strategic SWOT Analysis Review

Date: June 16, 2015
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P878AF920E0EN
Leaflet:

Download PDF Leaflet

Pure Bioscience, Inc. (PURE) - Financial and Strategic SWOT Analysis Review
Pure Bioscience, Inc. (PURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pure Bioscience, Inc. (Pure) formerly Innovative Medical Services, is involved in the development and commercialization of its proprietary antimicrobial products. The company develops and markets technology-based bioscience products that offer non-toxic solutions to a number of global health challenges, including Staph (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. Pure’s technology platform is based on patented stabilized ionic silver, and products contain silver dihydrogen citrate, or SDC. SDC is an electrolytically generated source of stabilized ionic silver that formulates well with other compounds. The company currently manufactures and distributes SDC-based disinfecting and sanitizing products, which are registered by the Environmental Protection Agency, or EPA. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. SDC can serve as the basis for a broad range of products in diverse markets. Pure Bioscience is headquartered in El Cajon, California, the US.

Pure Bioscience, Inc. Key Recent Developments

Mar 04, 2015: PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results
Dec 09, 2013: PURE Bioscience Hosts Q1 Results Conference Call December 12, 2013
Nov 25, 2013: PURE Bioscience to Present at 6th Annual LD MICRO Conference
Aug 28, 2013: PURE Bioscience Strengthens Sales and Marketing Organization
Aug 13, 2013: PURE Bioscience Appoints New Board Members and Management Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Pure Bioscience, Inc. - Key Facts
Pure Bioscience, Inc. - Key Employees
Pure Bioscience, Inc. - Key Employee Biographies
Pure Bioscience, Inc. - Major Products and Services
Pure Bioscience, Inc. - History
Pure Bioscience, Inc. - Company Statement
Pure Bioscience, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Pure Bioscience, Inc. - Business Description
Pure Bioscience, Inc. - Corporate Strategy
Pure Bioscience, Inc. - SWOT Analysis
SWOT Analysis - Overview
Pure Bioscience, Inc. - Strengths
Strength - Focused R&D
Strength - Strong Patent Portfolio
Strength - Proprietary SDC Technology
Pure Bioscience, Inc. - Weaknesses
Weakness - History of Losses
Pure Bioscience, Inc. - Opportunities
Opportunity - Biotech Focus
Opportunity - Strategic Initiatives
Opportunity - Growing Market Opportunities in Emerging Markets
Pure Bioscience, Inc. - Threats
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Pure Bioscience, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Pure Bioscience, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 04, 2015: PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results
Oct 28, 2014: PURE Bioscience Reports Fiscal Year End 2014 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pure Bioscience, Inc., Key Facts
Pure Bioscience, Inc., Key Employees
Pure Bioscience, Inc., Key Employee Biographies
Pure Bioscience, Inc., Major Products and Services
Pure Bioscience, Inc., History
Pure Bioscience, Inc., Key Competitors
Pure Bioscience, Inc., Ratios based on current share price
Pure Bioscience, Inc., Annual Ratios
Pure Bioscience, Inc., Interim Ratios
Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Pure Bioscience, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Pure Bioscience, Inc., Performance Chart (2010 - 2014)
Pure Bioscience, Inc., Ratio Charts
Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pure Bioscience, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Pure Bioscience, Inc. (PURE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: